| MDLZ |
Report |
Organic Net Revenue Growth |
BEAT |
pred ~0.9% vs. cons 0.75% |
MEDIUM |
| MDLZ |
Report |
Volume/mix |
BEAT |
pred ~-1.0% vs. cons -1.24% |
MEDIUM |
| MDLZ |
Report |
Adjusted EPS |
BEAT |
pred ~$0.690 vs. cons $0.679 |
MEDIUM |
| MDLZ |
Guide |
FY26 Organic Net Revenue Growth |
UNCHANGED |
guide ~0%–2% vs. cons 1.74% |
MEDIUM |
| MDLZ |
Guide |
FY26 Adjusted EPS Growth, CC |
BETTER |
guide ~0%–5% vs. cons ~0% |
MEDIUM |
| MDLZ |
Guide |
Q3 volume/tone |
LOWER |
guide ~sequential improvement but soft U.S. vs. cons +0.62% volume/mix |
LOW |
| MDLZ |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
LOW |
| MDLZ |
Return |
5-day cumulative residual |
+1.5% (STABILIZE) |
STABILIZE — modest beat is offset by a maintained FY outlook |
LOW |